Sunovion Announces Results from Global Phase 2 Bipolar Depression Study
The following is a press release *** MARLBOROUGH – Sunovion Pharmaceuticals Inc., today, July 6, announced results from its depressive,
Read more
depression
The following is a press release *** MARLBOROUGH – Sunovion Pharmaceuticals Inc., today, July 6, announced results from its depressive,
Read more